A strange "werewolf syndrome" has been emerging in infants in Spain because their parents have consumed a popular hair-loss ...

Hims & Hers Health (NYSE:HIMS – Get Free Report) had its price objective increased by equities research analysts at Canaccord Genuity Group from $28.00 to $38.00 in a report released on ...

Dr. Lokesh, Associate Professor in the Department of General Medicine in the Hassan Institute of Medical Sciences, was ...

Hims & Hers Health, Inc. (NYSE:HIMS – Get Free Report) shares were up 6.6% during trading on Tuesday after Canaccord Genuity Group raised their price target on the stock from $28.00 to $38.00.

Eleven cases of hypertrichosis — commonly known as “werewolf syndrome” — has developed in babies throughout Spain.

2024年12月3日，保健护理服务公司Hims & Hers Health（HIMS）成交额为4.51亿美元，在当日美股中排第171名，成交额较昨日减少9.36%，当日成交量为1384.68万。

旧金山——根据监管文件显示，Hims & Hers Health, Inc.（纽约证券交易所代码：HIMS）首席执行官Andrew Dudum最近出售了33,513股A类普通股。这些股票于2024年12月2日以平均每股33.38美元的价格售出，总计约112万美元。

北京时间2024年12月04日02时28分，大树云（DSY.us）股票出现波动，股价急速拉升5.64%。截至发稿，该股报3.37美元/股，成交量2.3647万股，换手率0.04%，振幅4.39%。

Hims & Hers Health, Inc. ("Hims & Hers", NYSE: HIMS), the leading health and wellness platform, is proud to announce its ...

The American Diabetes Association is advising doctors and patients not to use compounded GLP-1s due to uncertainty about their content, safety, ...

Hims & Hers Health Inc is a multi-specialty telehealth platform that connects consumers to licensed healthcare professionals, ...

Zacks.com users have been paying close attention to Hims & Hers Health (HIMS). This makes it worthwhile to examine what the stock has in store.